University of Reims Champagne-Ardenne
University of Reims Champagne-Ardenne
1 Projects, page 1 of 1
assignment_turned_in Project2014 - 2017Partners:Gloucestershire Hospitals NHS Fdn Trust, URCA, Cobalt Light Systems Ltd, Gloucestershire Hospitals NHS Foundation Trust, Lancashire Teaching Hospitals NHS Trust +44 partnersGloucestershire Hospitals NHS Fdn Trust,URCA,Cobalt Light Systems Ltd,Gloucestershire Hospitals NHS Foundation Trust,Lancashire Teaching Hospitals NHS Trust,Lancaster University,Horiba UK Ltd,Bruker (United Kingdom),University of Exeter,UCL Hospitals NHS Foundation Trust,Monash University,Christie Hospital NHS Foundation Trust,Renishaw (United Kingdom),Robert Koch Institute,Christie Hospital NHS Trust,HORIBA Jobin Yvon IBH Ltd,Royal Devon and Exeter NHS Fdn Trust,Agilent Technologies (United Kingdom),University of Exeter,University of Reims Champagne-Ardenne,Lancaster University,Technological University Dublin,VS Consulting,The University of Manchester,University of Liverpool,UNIVERSITY OF EXETER,University of Manchester,University of Liverpool,Diamond Light Source,RKI,Keele University,Keele University,COBALT LIGHT SYSTEMS LIMITED,Agilent Technologies (United Kingdom),Diamond Light Source,PerkinElmer (United Kingdom),University College London Hospital (UCLH) NHS Foundation Trust,Bruker UK Ltd,VS Consulting,Monash University,Imperial College London,PERKINELMER LAS (UK) LIMITED,Bruker UK Ltd,RD&E,University of Salford,Lancashire Teaching Hospitals NHS Foundation Trust,Renishaw plc (UK),RENISHAW,UCLFunder: UK Research and Innovation Project Code: EP/L012952/1Funder Contribution: 188,406 GBPA major part of the diagnosis of any disease but particularly various forms of cancer, is obtained though a biopsy. This involves removing a small sample of tissue, or a few cells, from the patient. These samples, either tissue or cells are then examined by a pathologist looking down an optical microscope. In most cases the sample is stained with a combination of dyes to help gain some contrast. In most cases, based upon visual inspection of the sample a diagnosis is made. This process if far from ideal since it relies on the expertise of the clinician concerned as is subject to intra in inter observer error. Recently a number of proof of concept studies have shown that molecular spectroscopic techniques such as infrared and Raman are capable of distinguishing diseased from non diseased cells and tissue based upon the inherent chemistry contained within the cells. The UK is at the forefront of these developments but there are many hurdles that need to be overcome if this technology is to move from the proof of concept stage through the translational stage and into the clinical setting. It is the belief of the academic community that we are much more likely to overcome these hurdles if we pool our resources, bring in both industrial and clinical partners and work on these generic problems together. This application is for funding to support such a network of partners for the next three years.
All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::7996a0b9ed03d2b7d277ae3b1f64f38b&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eumore_vert All Research productsarrow_drop_down <script type="text/javascript"> <!-- document.write('<div id="oa_widget"></div>'); document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=ukri________::7996a0b9ed03d2b7d277ae3b1f64f38b&type=result"></script>'); --> </script>
For further information contact us at helpdesk@openaire.eu